Our findings demonstrates that methylation changes of CD4+ T cells are prominent at mid-pregnancy, and that these changes could be an important immune regulatory mechanism during pregnancy, contributing to the pregnancy-induced modulation of MS, RA and SLE. This evidence concerns the gene CD4 and myeloid sarcoma.